Alzheimer Disease and the Role of Free Radicals in the Pathogenesis of the Disease

被引:1
作者
Moreira, Paula I. [2 ]
Santos, Maria S. [2 ]
Oliveira, Catarina R. [2 ]
Shenk, Justin C. [1 ]
Nunomura, Akihiko [3 ]
Smith, Mark A. [4 ]
Zhu, Xiongwei [4 ]
Perry, George [1 ,4 ]
机构
[1] Univ Texas San Antonio, Coll Sci, San Antonio, TX 78249 USA
[2] Univ Coimbra, Ctr Neurosci & Cell Biol Coimbra, P-3004517 Coimbra, Portugal
[3] Asahikawa Med Coll, Dept Psychiat & Neurol, Asahikawa, Hokkaido 0788510, Japan
[4] Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA
基金
美国国家卫生研究院;
关键词
Alzheimer disease; antioxidant; chelator; iron; mitochondria; oxidative stress; reactive oxygen species;
D O I
暂无
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Oxidative stress occurs early in the progression of Alzheimer disease, significantly before the development of the pathologic hallmarks, neurofibrillary tangles and senile plaques. All classes of macromolecules (sugar, lipids, proteins, and nucleic acids) are affected by oxidative stress leading, inevitably, to neuronal dysfunction. Extensive data from the literature support the notion that mitochondrial and metal abnormalities are key sources of oxidative stress in Alzheimer disease. Furthermore, it has been suggested that in the initial stages of the development of Alzheimer disease, amyloid-beta deposition and hyperphosphorylated tau function as compensatory responses to ensure that neuronal cells do not succumb to oxidative damage. However, during the progression of the disease, the antioxidant activity of both agents is either overwhelmed or, according to others, evolves into pro-oxidant activity resulting in the exacerbation of reactive species production.
引用
收藏
页码:3 / 10
页数:8
相关论文
共 160 条
[1]   β-amyloid peptides induce mitochondrial dysfunction and oxidative stress in astrocytes and death of neurons through activation of NADPH oxidase [J].
Abramov, AY ;
Canevari, L ;
Duchen, MR .
JOURNAL OF NEUROSCIENCE, 2004, 24 (02) :565-575
[2]   Increased density of metallothionein I/II-immunopositive cortical glial cells in the early stages of Alzheimer's disease [J].
Adlard, PA ;
West, AK ;
Vickers, JC .
NEUROBIOLOGY OF DISEASE, 1998, 5 (05) :349-356
[3]   Protein oxidation in the brain in Alzheimer's disease [J].
Aksenov, MY ;
Aksenova, MV ;
Butterfield, DA ;
Geddes, JW ;
Markesbery, WR .
NEUROSCIENCE, 2001, 103 (02) :373-383
[4]   Mitochondria and vascular lesions as a central target for the development of Alzheimer's disease and Alzheimer disease-like pathology in transgenic mice [J].
Aliev, G ;
Seyidova, D ;
Lamb, BT ;
Obrenovich, ME ;
Siedlak, SL ;
Vinters, HV ;
Friedland, RP ;
LaManna, JC ;
Smith, MA ;
Perry, G .
NEUROLOGICAL RESEARCH, 2003, 25 (06) :665-674
[5]   Mitochondrial targeting and a novel transmembrane arrest of Alzheimer's amyloid precursor protein impairs mitochondrial function in neuronal cells [J].
Anandatheerthavarada, HK ;
Biswas, G ;
Robin, MA ;
Avadhani, NG .
JOURNAL OF CELL BIOLOGY, 2003, 161 (01) :41-54
[6]   Alzheimer's disease and the basal forebrain cholinergic system:: relations to β-amyloid peptides, cognition, and treatment strategies [J].
Auld, DS ;
Kornecook, TJ ;
Bastianetto, S ;
Quirion, R .
PROGRESS IN NEUROBIOLOGY, 2002, 68 (03) :209-245
[7]  
BASUN H, 1991, J NEURAL TRANSM-PARK, V3, P231
[8]   HYDROGEN-PEROXIDE MEDIATES AMYLOID-BETA PROTEIN TOXICITY [J].
BEHL, C ;
DAVIS, JB ;
LESLEY, R ;
SCHUBERT, D .
CELL, 1994, 77 (06) :817-827
[9]   The permeability transition pore. Control points of a cyclosporin A-sensitive mitochondrial channel involved in cell death [J].
Bernardi, P .
BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS, 1996, 1275 (1-2) :5-9
[10]   Alzheimer's disease [J].
Blennow, Kaj ;
de Leon, Mony J. ;
Zetterberg, Henrik .
LANCET, 2006, 368 (9533) :387-403